Sionna Therapeutics, Inc.SION

$37.30+0.57 (+1.55%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$2B

Small-cap

+67%

2025 — today

10-Year Price

+64%

2025 — today

52-Week Range

$14.10$45.95

Current $37.30· 73%

Operating as a biopharmaceutical company, Sionna Therapeutics, Inc. is dedicated to transforming the treatment landscape for individuals with cystic fibrosis. This is achieved by developing innovative medicines designed to restore the normal function of the cystic fibrosis transmembrane conductance regulator.

Valuation in context

P/E ratio

-19.3

N/A

Not meaningful — company is unprofitable

P/B ratio

5.8

Historically pricey

Historically pricey — last 10 years

FCF Yield

-4.3%

Above average

Above the 10-year average

Free · No credit card needed

Get alerted when SION is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.